Off The Scales: The Inside Story of GLP-1s and the Race to Cure Obesity

Off The Scales: The Inside Story of GLP-1s and the Race to Cure Obesity

Off The Scales: The Inside Story of GLP-1s and the Race to Cure Obesity
Format
Audiobook
Listen anywhere
$17.16
Support the people who made thisYour purchase supports the people who made this work

Description

The inside story of the race to develop Ozempic – the world’s first truly effective and safe obesity drug – and its potentially revolutionary effects on public health, and our deeper culture and values.

'A FASCINATING DEEP DIVE' Guardian

'VERY ENGAGING' New Scientist

'ENLIGHTENING' Publishers Weekly

A ‘cure’ for obesity has long evaded the pharmaceutical industry, until the development of Ozempic: a diabetes medication that targets the GLP-1 hormone and makes people feel fuller for longer.

After decades of research, Ozempic’s creator Novo Nordisk

Product details

Publisher
HarperCollins UK
Narrated by
Yael Rizowy
Release date
November 18, 2025
Length
7 h 26 min
Total file size
204 MB
Audio
14 chapters
Edition
Unabridged
Language
English
ISBN
9780008719111
||
Recommendations